Over the past 5 decades or so, the growing understanding that RNA can influence protein function through routes other than direct translation has opened the …

Kindeva Drug Delivery is a contract development and manufacturing organisation (CDMO) specialising in complex drug formulation and delivery. Seeking to scale its production of coated …

Achieving investigational new drug (IND) approval at an increasingly faster rate than competitor drugs is a widespread desire of biologics developers. This has been further …

3D printing or additive manufacturing (AM) technology has considerable potential to more closely align tablet manufacture with modern requirements and is a growing area of …

Driven by advances in oncology treatments and personalised precision medicine, two trends are converging to increasingly challenge pharma’s developers and their external contract manufacturing suppliers: …

The solid form of a drug substance has a huge bearing on its formulation as a drug product. In an ideal world, every API would …

By 2028, the global market for injectable drugs is set to reach $69.13 billion, growing at a CAGR of 8.9%. There are many reasons for …

Modular building technologies have well proven to meet the pharmaceutical industry’s demanding capacity and speed imperatives. For the last three decades or more, biopharma’s growth …

The biologic market has grown expediently over the past few years, driven not only by the pandemic but also by the increasing demand for innovative …

In liquid pharmaceuticals, the stakes could not be higher: the correct dosage and usage can literally be a matter of life and death. Marco Pelka, …